Incidence of Dyslipidemia Elevated During COVID-19 Pandemic
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 14, 2024 -- There was an increase in dyslipidemia incidence during the COVID-19 pandemic compared with the prepandemic period, according to a study published online Sept. 12 in the Journal of Clinical Investigation.
Valentina Trimarco, from Federico II University in Naples, Italy, and colleagues conducted a six-year longitudinal study to examine the broader effects of COVID-19 on the incidence of dyslipidemia in a real-world population of 228,266 individuals. Dyslipidemia incidence was compared during the COVID-19 pandemic (2020 to 2022) to the prepandemic period (2017 to 2019), with follow-up of at least 1,095 days (21,349,215 person-years).
The researchers found that the risk for developing dyslipidemia was increased during the COVID-19 period compared with the pre-COVID-19 period (odds ratio, 1.29), after adjustment for comorbidities in a multivariate analysis.
"The main finding of our study is the observation that the increased risk of dyslipidemia during the COVID-19 pandemic involved not only patients who had severe acute respiratory syndrome coronavirus 2 infection but the whole population," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Further Support and Information on COVID-19
Read this next
Postpandemic Hospital Occupancy Up to 73.5 Percent, Sparking Concern
FRIDAY, Feb. 21, 2025 -- Postpandemic hospital occupancy is higher than prepandemic and is expected to continue increasing without changes in the hospitalization rate or staffed...
Diabetes, Dyslipidemia Screening Rates Low After Pregnancy, Even for Those With HTN, GDM
FRIDAY, Feb. 21, 2025 -- Patients with pregnancy-related hypertension (HTN) or diabetes are more likely to be screened for diabetes and dyslipidemia after delivery, but screening...
In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition
WEDNESDAY, Feb. 12, 2025 -- Post-COVID condition (PCC) continues to affect children, and 80 percent of those currently experiencing PCC have activity limitation, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.